ImmunologybioRxiv
Integrated plasma proteomic and single-cell immune signaling network signatures demarcate mild, moderate, and severe COVID-19
D. Feyaerts, J. Hedou, J. Gillard…·D. R. McIlwain
This study integrates plasma proteomics and single-cell immune features to classify COVID-19 severity and identify biological signatures of disease progression.
DOI 10.1016/j.xcrm.2022.100680